Navigation Links
Olympus FluoroPoint(TM) System Provides High-Sensitivity Single Molecule and Protein Interaction Analysis for Screening and Research
Date:4/4/2008

ffers fluorescence correlation spectroscopy (FCS), molecular brightness (FIDA), and confocal anisotropy (FIDA-PO) measurements, all in an automated, user-friendly format. Its mix-and-measure simplicity means that researchers do not have to do any washing or other complicated preparatory efforts. Data is available as quickly as 0.5 seconds per well, depending on the measurements collected.

For more information on the Olympus FluoroPoint molecular interaction analysis system, contact Olympus America Inc., 3500 Corporate Parkway, Center Valley PA 18034-0610; phone 1-908-596-0417; visit http://www.olympusamerica.com/FluoroPoint or email FluoroPoint@olympus.com.

About Olympus Products for Life Science, Biotechnology and Pharmaceutical Research

Olympus America is a recognized leader in applying optical technology for life science research. With proven expertise in providing advanced systems to power research, Olympus delivers a portfolio of products for drug discovery, biotechnology and the life sciences, including microscopes, endoscopes and surgical instruments, along with diagnostic and scientific instruments, cameras and software.

About Olympus

Olympus is a precision technology leader, creating innovative opto-digital solutions in healthcare, life science and consumer electronics products. Olympus works collaboratively with its customers and its affiliates worldwide to leverage R&D investment in precision technology and manufacturing processes across diverse business lines. These include:
-- Gastrointestinal endoscopes, accessories, and minimally invasive

surgical products;

-- Advanced clinical and research microscopes;

-- Lab automation systems, chemistry-immuno and blood bank analyzers and

reagents;

-- Digital cameras and voice recorders.

Olympus serves health
'/>"/>

SOURCE Olympus
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Olympus Capital Announces Agreement to Sell Arysta LifeScience Corporation
2. PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business
3. Cardiums InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems
4. Augusta Systems Technologies Integrated into Ciscos Newly Launched Safety and Security Platform
5. WaferGen Signs Exclusive Distribution Agreement for SmartSlide(TM) Micro-Incubation System in Germany
6. Cardiac Science Signs Letter of Intent With Misys Healthcare Systems to Connect With Their EMR Systems
7. Biotage Launches New 24 Well Pyrosequencing(R) System
8. Beaumont Hospitals in Michigan Selects Halogen Software for Pay for Performance System
9. Microfluidic Systems to Show Automated Biological Agent Detection Technology to U.S. House of Representatives
10. World Debut for BSPs HyperQ Stress System: 57th Annual American College of Cardiology Meeting 2008
11. Varian Medical Systems Schedules Second Quarter FY2008 News Release and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... WA (PRWEB) , ... August 03, 2015 , ... ... and TLD5000 diaphragm vacuum pumps to its comprehensive line of analytical laboratory equipment. ... steel valves, these versatile pumps provide a chemically resistant and maintenance-free solution for ...
(Date:7/31/2015)... 2015 China Cord Blood Corporation (NYSE: CO) ... leading provider of cord blood collection, laboratory testing, hematopoietic ... announced that the Company has filed its Annual Report ... Commission. The filed Form 20-F includes audited financial statements ... Form 20-F can be accessed by visiting the U.S. ...
(Date:7/30/2015)... AACC welcomed thousands of medical professionals ... Meeting & Clinical Lab Expo in ... showcased revolutionary advancements in clinical testing technology and ... to diagnose patients quickly and accurately and make ... As of Wednesday, July 29, more than ...
(Date:7/30/2015)... , ... July 30, 2015 , ... The 2015 Market ... study on the current state of the global Propanol market with a focus on ... BASF, Eastman, Dow, Carboclor, Mitsui Chemicals, Oxea, ISU Chemical, Sanofi, Royal Dutch Shell, LG ...
Breaking Biology Technology:Sterlitech Launches New Line of Vacuum Pumps 2China Cord Blood Corporation Files Its Annual Report on Form 20-F 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 4Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3
... Inc. (OTC Bulletin Board: GOVX ), a biotechnology ... announced the results of its Annual Shareholders Meeting, held on ... seven nominees for directors of the company to serve until ... are duly elected or appointed and qualified. They are: ...
... VPRIV(R) (velaglucerase alfa) for the Treatment of... -- CAMBRIDGE, Massachusetts, August 26, 2010 ... ... --> ... { var s = ,; var first_result; // Results are keyed by longUrl, so we need ...
... Calif., Aug. 26 CreAgri, Inc. ®  announced ... by the Australian Patent Office, Patent Number 2003249719, ... against skin damage caused by UV exposure. ... include formulations containing the two most important olive ...
Cached Biology Technology:GeoVax Labs Inc. Announces Results of 2010 Annual Stockholders Meeting 2GeoVax Labs Inc. Announces Results of 2010 Annual Stockholders Meeting 3GeoVax Labs Inc. Announces Results of 2010 Annual Stockholders Meeting 4Shire Announces European Approval of VPRIV(R) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease 2Shire Announces European Approval of VPRIV(R) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease 3Shire Announces European Approval of VPRIV(R) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease 4Shire Announces European Approval of VPRIV(R) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease 5Shire Announces European Approval of VPRIV(R) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease 6Shire Announces European Approval of VPRIV(R) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease 7Shire Announces European Approval of VPRIV(R) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease 8Shire Announces European Approval of VPRIV(R) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease 9Australian Patent Issued to CreAgri® for Ultraviolet Radiation (UVR) Protection by its Hydroxytyrosol-Based Formulations 2Australian Patent Issued to CreAgri® for Ultraviolet Radiation (UVR) Protection by its Hydroxytyrosol-Based Formulations 3
(Date:7/31/2015)... 31 de julio de 2015 La 10 th ... celebrará por medio de BGI del 22 al 25 de octubre ... Este año, la conferencia celebra su décimo aniversario. ... convertido en una de las reuniones anuales más influyentes del ... las reuniones más dinámicas, entusiastas y mejores a nivel científico. ...
(Date:7/30/2015)... 30, 2015 Cellecta, Inc., a U.S.-based ... analysis and biomarker discovery, announced the release of ... targeting all human protein coding genes. CRISPR technology ... a gene,s function. Cellecta,s new Human Whole Genome ... tool so that researchers can investigate in a ...
(Date:7/23/2015)... July 23, 2015 Research and Markets ... the "Global Outlook of the Biometrics Industry ... The global biometrics market is likely ... commercial applications owing to the uptake of multiple ... transformation that enhances the growth of biometrics in ...
Breaking Biology News(10 mins):La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3
... grow, a researcher at MIT's Picower Institute for Learning and ... of Science (PLoS) Biology that structural remodeling of neurons does ... means that it may one day be possible to grow ... cord injury, such as the one that paralyzed the late ...
... Max Planck researchers uncover how a nanoscale 'compass' inside ... The entire bacterium is oriented like a compass needle ... clear how the cells organise magnetosomes into a stable ... attraction. But using modern molecular-genetic and imaging processes, researchers ...
... Scientists from the National Institute of Allergy and ... of Health, have determined how a promising drug ... Published online this week in Proceedings of the ... scientists optimize the drug candidate, PA-824, which targets ...
Cached Biology News:MIT researcher finds neuron growth in adult brain 2MIT researcher finds neuron growth in adult brain 3Bacteria which sense the Earth's magnetic field 2Bacteria which sense the Earth's magnetic field 3Bacteria which sense the Earth's magnetic field 4NIAID researchers show how promising TB drug works 2NIAID researchers show how promising TB drug works 3
ID clarifier: Without ethidium bromide...
... Biotin Streptavidin-HRP Systems provide rapid, precise ... antigens in frozen or paraffin-embedded tissue, ... systems also facilitate double or triple ... performed simultaneously with primary antibodies of ...
...
... covers can be used with ... covers for stacking of covered ... for use with automated systems ... and non-ridged, are available for ...
Biology Products: